Head-to-head comparison of [18F]FDG PET/MRI and [18F] FDG PET/CT for TNM staging in non-small cell lung cancer: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Head-to-head comparison of [18F]FDG PET/MRI and [18F] FDG PET/CT for TNM staging in non-small cell lung cancer: a systematic review and meta-analysis

Published:2024-02-23 Issue:4 Volume:12 Page:413-421
ISSN:2281-7565
Container-title:Clinical and Translational Imaging
language:en
Short-container-title:Clin Transl Imaging

Author:

Li Zhiwei,Sun Dianhan,Li Anying,Shu Yusheng^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40336-024-00622-7.pdf

Reference35 articles.

1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J Clin 68(6):394–424. https://doi.org/10.3322/caac.21492

2. Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA (2008) Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc 83(5):584–594. https://doi.org/10.4065/83.5.584

3. National Comprehensive Cancer Network. (2021). NCCN clinical practice guidelines in oncology: Non-small cell lung cancer, Version 3.2021. https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf.

4. Wang M-l, Zhang H, Yu H-j, Tan H, Hu L-z, Kong H-j et al (2023) An initial study on the comparison of diagnostic performance of 18F-FDG PET/MR and 18F-FDG PET/CT for thoracic staging of non-small cell lung cancer: Focus on pleural invasion. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition). 42(1):16–23. https://doi.org/10.1016/j.remnie.2021.12.007

5. Biederer J, Beer M, Hirsch W, Wild J, Fabel M, Puderbach M et al (2012) MRI of the lung (2/3). Why… when… how? Insights imaging 3(4):355–371. https://doi.org/10.1007/s13244-011-0146-8